Abiopharma

🔍 Simmons Jeffrey N (Executive)

Company: Elanco Animal Health Inc (ELAN)

Report Date: 2025-12-11

Detailed Transactions and Holdings:

• Acquired 22,000 shares of Common Stock at $21.7498 per share (Direct)
  Date: 2025-12-11 | Code: P | equity_swap_involved: 0 | shares_owned_after: 167,000.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-12-11 | Code: H | shares_owned_after: 1,802,380.00 | Footnotes: F2

Footnotes:

• F1: Reflects the weighted average price of 22,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on December 11, 2025 with purchase prices ranging from $21.739 to $21.75 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
• F2: Includes 1 share acquired on April 30, 2025 under Elanco Animal Health Inc.'s Employee Stock Purchase Plan.